Atlas Trials

Safety and Efficacy of LMWH Versus Rivaroxaban in Chinese Patients Hospitalized With Acute Coronary Syndrome

Clinical trial NCT03363035 · COMPLETED

Trial details

NCT number
NCT03363035
Sponsor
Second Xiangya Hospital of Central South University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Acute Coronary SyndromeMyocardial InfarctionMyocardial IschemiaUnstable Angina
Start date
2018-01-15
Primary completion
2021-11-11
Enrollment
2055

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.